| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $32.1M | +1.2% |
| SG&A Expense | $5.9M | -10.2% |
| Operating Income | -$38.1M | +0.7% |
| Interest Expense | $2.8M | +170.3% |
| Net Income | -$41.1M | -5.9% |
| EPS (Basic) | -$0.74 | -13.8% |
| EPS (Diluted) | -$0.74 | -13.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.7M | +38.0% |
| Current Assets | $27.7M | +34.8% |
| Total Assets | $28.2M | +32.5% |
| Current Liabilities | $15.7M | +20.5% |
| Total Liabilities | $88.4M | +65.4% |
| Stockholders' Equity | -$62.0M | -82.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.0M | -6.1% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $40.0M | +300.3% |